Previous 10 | Next 10 |
Denali Therapeutics (NASDAQ: DNLI ) initiated with Buy rating and $35 (84% upside) price target at Nomura Instinet. More news on: Denali Therapeutics Inc., Intuitive Surgical, Inc., ACADIA Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Thinly traded nano cap Ritter Pharmaceuticals (NASDAQ: RTTR ) is poised for a significant down move after announcing that a Phase 3 clinical trial evaluating lead candidate RP-G28 for the treatment of lactose intolerance (LI) failed to achieve the primary endpoint. More news on: Ritter...
LOS ANGELES, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, annou...
Ritter Pharmaceuticals (NASDAQ: RTTR ): Q2 GAAP EPS of -$0.31 beats by $0.18 . More news on: Ritter Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
LOS ANGELES, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases with an init...
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal (GI) diseases, today ...
Market research indicates an unmet need for better lactose intolerance treatments and interest from both patients and physicians in the RP-G28 drug profile LOS ANGELES, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”...
Daniel P. Lundberg, Consultant to Ritter Pharmaceuticals and former Senior VP of Marketing at Salix Pharmaceuticals to address market opportunity for Phase 3, lactose intolerance drug candidate RP-G28 LOS ANGELES, July 31, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: R...
Medigus (NASDAQ: MDGS ) +49% on large order for visualization device. More news on: Medigus Ltd., VivoPower International PLC, HOOKIPA Pharma Inc., Stocks on the move, Read more ...
Ritter Shares Will Continue to Trade on the Nasdaq Capital Market LOS ANGELES, July 11, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that mo...
News, Short Squeeze, Breakout and More Instantly...
Ritter Pharmaceuticals Company Name:
RTTR Stock Symbol:
NASDAQ Market:
LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger transaction with Qualigen, Inc. is currently expected to close...
LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), announced today that, based upon the final vote count certified by the inspector of election for the s...
Will These Penny Stocks Stay Below $2? Penny stocks are always considered high-risk, high-reward equities. But many investors still have a hard time with the standard definition of penny stocks . According to the Securities and Exchange Commission, penny stocks are shares of public companie...